These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7124729)

  • 1. Fifteen-year experience with screening for phenylketonuria with an automated fluorometric method.
    Kirkman HN; Carroll CL; Moore EG; Matheson MS
    Am J Hum Genet; 1982 Sep; 34(5):743-52. PubMed ID: 7124729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.
    Hanley WB; Demshar H; Preston MA; Borczyk A; Schoonheyt WE; Clarke JT; Feigenbaum A
    Early Hum Dev; 1997 Jan; 47(1):87-96. PubMed ID: 9118832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
    Chace DH; Sherwin JE; Hillman SL; Lorey F; Cunningham GC
    Clin Chem; 1998 Dec; 44(12):2405-9. PubMed ID: 9836704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
    González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
    Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria.
    Schulze A; Mayatepek E; Hoffmann GF
    Clin Chim Acta; 2002 Mar; 317(1-2):27-37. PubMed ID: 11814455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria variants in Ontario.
    Can Med Assoc J; 1976 Sep; 115(6):509-12. PubMed ID: 953933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the "report on a cooperative study of various fluorometric procedures and the Guthrie Bacterial Inhibition Assay in the determination of hyperphenylalaninemia" and the significance of this study in the detection, diagnosis, and management of phenylketonuria (PKU).
    Ambrose JA
    Health Lab Sci; 1973 Jul; 10(3):188-94. PubMed ID: 4720477
    [No Abstract]   [Full Text] [Related]  

  • 10. Early blood sampling in neonatal programs for the detection of phenylketonuria.
    Szeinberg A; Cohen BE
    Padiatr Padol; 1982; 17(2):287-92. PubMed ID: 7099682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylketonuria screening with a fluorometric microplate assay.
    Lubenow N; Diepenbrock F; Schickling H; Bock D; Heckler R; Sander J
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):525-8. PubMed ID: 7981333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for phenylketonuria: predictive validity as a function of age.
    McCabe ER; McCabe L; Mosher GA; Allen RJ; Berman JL
    Pediatrics; 1983 Sep; 72(3):390-8. PubMed ID: 6889045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On indications for treatment of the hyperphenylalaninemic neonate.
    Güttler F; Wamberg E
    Acta Paediatr Scand; 1977 May; 66(3):339-44. PubMed ID: 868515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria detected by the neonatal screening program in Thailand.
    Pangkanon S; Ratrisawadi V; Charoensiriwatana W; Techasena W; Boonpuan K; Srisomsap C; Svasti J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():179-81. PubMed ID: 15906730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What disorders suspect following an increase of phenylalanine on newborn screening?].
    Michel MA; Raucourt E; Bednarek N; Garnotel R
    Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria: contemporary screening and diagnosis.
    Mabry CC
    Ann Clin Lab Sci; 1990; 20(6):393-7. PubMed ID: 2073089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program of neonatal screening for phenylketonuria].
    Cornejo V; Raimann E; Moraga M; Colombo M
    Rev Chil Pediatr; 1990; 61(6):309-12. PubMed ID: 2152214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.
    Hennermann JB; Loui A; Weber A; Mönch E
    J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn phenylalanine/tyrosine metabolism. Implications for screening for phenylketonuria.
    Schneider AJ
    Am J Dis Child; 1983 May; 137(5):427-32. PubMed ID: 6846269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography.
    Reilly AA; Bellisario R; Pass KA
    Clin Chem; 1998 Feb; 44(2):317-26. PubMed ID: 9474031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.